In vivo validation of psilacetin as a prodrug yielding modestly lower peripheral psilocin exposure than psilocybin - N. Jones; Laura M. Wagner; Molly C. Pellitteri Hahn; Cameron O. Scarlett; Cody J. Wenthur (Frontiers in Psychiatry, 2024)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com